We guide healthcare, pharmaceutical, biotech and medical device companies through institutional, regulatory and market access processes.

Transforming regulatory complexity into strategic positioning.
POSITIONING

The Italian healthcare system is complex, fragmented and constantly evolving.

MPA supports pharmaceutical, biotech and medical device companies, as well as healthcare providers, in navigating  the institutional, regulatory and reputational dynamics that influence market access, positioning and growth.

We act  as an integrated strategic partner, combining  a results-oriented approach with deep expertise in national and regional decision-making processes.

Strategy. Relationships. Access. Results.

MPA

Operational presence in industrial hubs and institutional context.
ABOUT US

Partner strategico nei contesti ad alta complessità.

MPA was founded  to help  healthcare and life sciences organisations navigate  the institutional, regulatory and strategic dynamics that shape the Italian healthcare system.

We work alongside executive  teams to develop and implement  effective strategies across:

Our model integrates strategic analysis, regulatory intelligence, institutional engagement,  and operational execution, ensuring continuity between strategic objectives  and measurable outcomes.

With offices in Milan and Rome, we provide direct coverage of  both  national and regional decision-making environments, helping  clients  strengthen their position within the Italian healthcare ecosystem.

Why MPA

Deep understanding of the Italian healthcare decision-making landscape

MPA helps   organisations  manage institutional engagement  and market access pathways through an integrated, pragmatic and results-oriented approach.

What sets us apart

We do not simply provide consultancy.

We build strategic positioning and access pathways.

PRACTICE AREAS

Problem → Solution → Result.

6 integrated areas

A clear structure to make the services easy to understand and strengthen the consultancy’s positioning.

01

Government Affairs

Strategic management of institutional relations

We support companies in their engagement  with national and regional institutions by monitoring regulatory developments and developing  institutional strategies aligned with business  objectives.

Activities

  • Regulatory and legislative monitoring
  • Regulatory impact assessment  
  • Institutional engagement strategies
  • Support in relations with Ministries, AIFA, Parliament and Regional Authorities
  • Position papers and technical documentation

Objective

To foster solid and sustainable institutional positioning.

02

Public Affairs

Building relationships that create value

We develop stakeholder engagement strategies designed to strengthen the company’s positioning within the healthcare system.

Activities

  • Stakeholder mapping
  • Engagement strategy development
  • Technical roundtables and institutional meetings
  • Advocacy programmes
  • Strategic partnerships

Objective

To facilitate constructive and authoritative dialogue among companies, institutions and healthcare stakeholders.

03

Market & Value Access – National Level

Accelerating market access pathways

We support companies in demonstrating the clinical, economic and institutional value of therapeutic innovations.

Activities

  • HTA analysis and regulatory landscape assessment
  • Support in the preparation of technical and scientific dossiers
  • Market access strategies
  • Cross-functional coordination

Objective

To maximise recognition of therapeutic value and facilitate sustainable access pathways.

04

Market & Value Access – Regional Level

Bridging regional access gaps

We support the regional adoption of national access decisions and the management of territorial processes.

Activities

  • Regional formularies and regional processes
  • Monitoring of regional adoption processes
  • Engagement with Regional Committees
  • Territorial access and implementation strategies

Objective

To accelerate patients’ access to innovative therapies across regions.

05

Patient Advocacy

Patients as strategic stakeholders

We foster collaboration pathways between companies and patient associations while ensuring   full compliance with transparency and ethical standards.

Activities

Objective

To integrate patient needs into healthcare decision-making and access pathways.

06

Institutional Communication

Strengthening authority and reputation

We develop institutional narratives consistent with the company’s strategic positioning.

Activities

  • Institutional storytelling
  • Position papers
  • Institutional events
  • Crisis communication support
  • Corporate communication coordination

Objective

To enhance credibility and visibility among stakeholders and institutions.

OUR METHOD

Each project is developed through a structured and highly tailored approach.

We build strategic positioning paths.

01

Analysis

We assess the regulatory landscape, stakeholders, competitive context and critical issues.

02

Strategy

We define objectives, priorities and an action plan.

03

Execution

We operationally manage activities, relationships and coordination.

04

Monitoring

We measure results, regulatory developments and emerging opportunities.

Contacts

Contact us to discuss your strategic advisory needs.

Transforming regulatory complexity into strategic value.